Aditum Bio Management

Venture Capital Exempt reporting adviser

Legal name: Aditum Bio Management Company, LLC

Oakland, CA Website LinkedIn

AUM

$772.8M
Private fund assets

Private funds

3
Venture Capital 3

Private fund assets

$772.8M
Gross asset value

Employees

—

Last Form D raise

May 2024
Most recent fund filing

From SEC Form ADV filing (filed Mar 31, 2026). View on SEC

People(6)

Owners and executive officers named on the firm's SEC Form ADV.

C
Managing Director of Aditum Bio GP 2, LLC & Aditum Bio GP 3, LLC
J
Managing Director of Aditum Bio GP 3, LLC
M
Co-Founder and Chairman of the Scientific Advisory Board
P
Managing Director of Aditum Bio GP 1, LLC
P
Managing Director of Aditum Bio GP 2, LLC & Aditum Bio GP 3, LLC

Funds(3)

Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.

FundTypeGross assetsRaised (Form D)InvestorsLast Form DRecency
Aditum Bio Fund 3, L.P.Venture Capital$413.7M——May 2024Cold
Aditum Bio Fund 2, L.P.Venture Capital$179.6M——Jul 2021Cold
Aditum Bio Fund 1, L.P.Venture Capital$179.5M$133.0M26Oct 2020Cold

Board seats(3)

Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.

Tempero Bio
BiotechnologyOakland, CADirector: Joshua Gertsman
$77.0M raised
Since Nov 2025
SEC Form D
Tempero Bio
BiotechnologyOakland, CADirector: Joseph Jimenez
$77.0M raised
Since Nov 2025
SEC Form D
Via Nova Therapeutics
BiotechnologyOakland, CADirector: Joseph Jimenez
$5.0M raised
Since Sep 2021
SEC Form D

Regulatory identifiers

CRD number
305442
SEC file number
802-117529

Sources